Exploring the Role of Molecular Profiling: Using NGS in the Diagnosis and Treatment of Biliary Tract Cancers (BTC)

This webinar was initiated, funded and approved by Incyte.

The views and opinions expressed in this webinar are those of the individual speakers and do not necessarily reflect those of Incyte or EMJ. The speakers have/have not received honoraria for their participation in this recording.

In this webinar, clinical experts discuss how next-generation sequencing (NGS) can guide targeted treatment in biliary tract cancers, addressing key challenges such as limited tissue, testing access, and reimbursement. The experts provide practical guidance and a simple diagnostic algorithm to help clinicians prioritise molecular testing and improve patient care.

Speakers:

Nicola Normanno,¹ Angela Lamarca,² Albrect Stenzinger³

1. Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy
2. Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
3. University Hospital Heidelberg, Germany